Steven Johnson syndrome in patients with complications of elevated Alt and Ast levels: A Case Report

Tavia Yuliastuti Prastika; Fiedyia Wati Kusuma; Stevia Artha Natalia Purba

Authors

Tavia Yuliastuti Prastika General Practitioner Mulya Hospital Tangerang, Banten, Indonesia
Fiedyia Wati Kusuma Dermatovenereologist Mulya Hospital Tangerang, Banten, Indonesia
Stevia Artha Natalia Purba General Practitioner Mulya Hospital Tangerang, Banten, Indonesia

Keywords:

Sindrom Steven Johnson (SSJ), alanine aminotransferase (ALT),, aspartate aminotransferase (AST).

Abstract

Stevens-Johnson syndrome (SSJ) is an extremely rare, acute, and potentially life-threatening event; is an immune complex-mediated hypersensitivity reaction that is often associated with drug use. The aim of this study is to describe the Steven Johnson Syndrome experienced by patients with complications of increased ALT and AST levels. The patient is a 58-year-old male with complaints of red spots all over the body and fever before being admitted to the hospital. The skin rash increases in redness all over the body, there are loose and then burst bullae on the neck, chest, and back, it feels sore and burning, there are dry scars on the lips, nose, and ears, accompanied by complaints of red eyes, painful swallowing, and occasional coughing. The patient took dexamethasone, paracetamol, and allopurinol before symptoms appeared. The most common complications in SJS cases are respiratory problems including bronchopneumonia and moderate increases in transaminase enzyme levels that do not cause jaundice. Stopping previous drug consumption and prompt and appropriate treatment can reduce mortality rates.

References

J. Van Erp and K. Loyens, “Why external witnesses report organizational misconduct to inspectorates: A comparative case study in three inspectorates,” Adm. Soc., vol. 52, no. 2, pp. 265–291, 2020.

S. Murlistyarini, S. Prawitasari, and L. Setyowatie, Intisari Ilmu Kesehatan Kulit dan Kelamin. Universitas Brawijaya Press, 2018.

B. Setiyohadi, I. Alwi, M. Simadibrata, and S. Setiati, “Buku ajar ilmu penyakit dalam,” Jilid1. Ed. ke-5. Jakarta Pus. Pnb. Dep. Ilmu Penyakit Dalam FKUI, 2009.

R. Diana, T. Rahayu, E. P. Wirawan, M. E. Dhamayanti, D. Yuliarto, and M. E. Irawanto, “Pathophysiology and management therapy of Steven-Johnson Syndrome (SJS) and Toxic Necrolysis Epidermal (TEN),” J. Gen. Dermatology Venereol. Indones., pp. 28–39, 2021.

A. B. Wisan and F. Aviana, “Dermatosis Mengancam Jiwa: Sindrom Stevens-Johnson Diduga Akibat Methampyron,” Cermin Dunia Kedokt., vol. 49, no. 8, pp. 443–446, 2022.

S.-C. Yang et al., “The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in China,” J. Immunol. Res., vol. 2018, 2018.

M. Mockenhaupt, “Bullous drug reactions,” Acta Derm. Venereol., vol. 100, no. 5, pp. 122–134, 2020.

H. A. Pratama, A. Sofyan, and M. A. Munir, “SINDROM STEVEN JOHNSON: LAPORAN KASUS,” J. Med. Prof., vol. 5, no. 1, pp. 1–7, 2023.

A. Rahayu, R. Gustia, and R. Rahmatini, “Profil Sindrom Stevens Johnson pada Pasien Rawat Inap di RSUP Dr. M. Djamil Padang Periode Januari 2010 sampai Desember 2011,” J. Kesehat. Andalas, vol. 3, no. 2, 2014.

A. Harsono and A. Endaryanto, “SINDROM STEVEN-JOHNSON”.

Y. W. Rahmawati and D. M. Indramaya, “Studi Retrospektif: Sindrom Stevens-Johnson dan Nekrolisis Epidermal Toksik,” Period Dermatology Venereol, vol. 28, no. 2, pp. 68–76, 2016.

Y. Tamigoes and T. S. Dewi, “Terapi lesi oral pasien sindrom Stevens-Johnson disertai lupus erythematosus sistemik Oral lesion therapy in patients with Stevens-Johnson syndrome with systemic lupus erythematosus,” J. Kedokt. Gigi Univ. Padjadjaran, vol. 30, no. 3, pp. 181–188, 2018.

R. Indrastiti, A. Novitasari, and C. Arum, “Faktor Prediktor Sindrom Stevens-Johnson dan Nekrolisis Epidermal Toksik,” J. Kedokt. Muhammadiyah, vol. 5, no. 1, 2016.

M. A. Thaha, “Sindrom stevens-johnson dan nekrolisis epidermal toksis di RSUP MH Palembang periode 2006-2008,” Media Med. Indones., vol. 43, no. 5, pp. 234–239, 2009.